Investigation into the
Authenticity of Commercial Rhodiola rosea
Products by 1H NMR, HPLC-MS/MS, and HPTLC
Reviewed: Booker
A, Jalil B, Frommenwiler D, et al. The authenticity and quality of Rhodiola rosea products. Phytomedicine. October
31, 2015; [epub ahead of print]. doi:
10.1016/j.phymed.2015.10.006.
The root and rhizome of Rhodiola rosea (Crassulaceae) is widely used as an
ingredient in dietary supplements. The European Medicines Agency’s Community
Herbal Monograph lists the temporary relief of symptoms of stress, such as
fatigue and sensation of weakness, as health benefits.1 Most of the
evidence in support of improving mental fatigue has been from clinical studies
with the proprietary product SHR-5 (drug extract ratio 4:1; extraction solvent
70% ethanol; manufactured by the Swedish Herbal Institute; Göteborg, Sweden). Rhodiola crenulata (hong jing tian)
is the only official Rhodiola
species listed in the Chinese Pharmacopoeia,
but other species, such as R.
heterodonta, R.
quadrifida, R.
semenovii, and R. kirilowii, are used in traditional Chinese medicine (TCM) as
well.2 A
survey of R. crenulata raw materials from
drugstores and hospitals in China showed that a variety of Rhodiola
species are sold labeled as hong jing tian.3
The present work investigated
39 samples altogether, including R. rosea crude drug material (2), bulk powders (3), hard
capsule extracts (21), soft gel capsules (1), tablets (9) claiming to be R. rosea, and aqueous extracts of R. crenulata (3). The crude drug material
was used as reference material. Two of the products analyzed were combined with
vitamins and other herbal extracts. Most products (37) were not registered and
were readily available over the Internet and from retail outlets as food
supplements.
The researchers used proton nuclear
magnetic resonance (1H NMR), high-performance liquid chromatography–mass
spectrometry (HPLC-MS), and high-performance thin-layer chromatography (HPTLC)
to analyze the samples. Data from the 1H NMR analysis were subjected
to statistical evaluation by principal component analysis (PCA), but the model
appeared to poorly discriminate among products containing R. rosea extracts and those extracts
containing R. crenulata or other Rhodiola species. This may be due to the
presence of large amounts of glycosides and excipients, which may have been
similar enough to prevent grouping the various species into distinct clusters,
or the fact that the species are chemically similar.
The HPTLC analysis showed incorrect
labelling in seven products, based on the absence of rosavin, a marker compound
that is characteristic for R. rosea, and
the overall fingerprint, which was different from the R. rosea
reference material. In five of these products, the data showed the presence of
salidroside, indicating that the ingredient was made from a different Rhodiola species, e.g., R. crenulata or
R. quadrifida. One product contained the
amino acid 5-hydroxytryptophan (5-HTP) besides the excipients, and one did not
contain any identifiable substances. The identity of 5-HTP was confirmed by NMR
and HPLC-MS/MS data.
Comment: This
paper raises some questions about the authenticity of dietary supplements
labeled to contain R. rosea. Approximately 20% of the products analyzed were
mislabeled; a case of economic adulteration is the sale of 5-HTP, a naturally
occurring (e.g., in Griffonia simplicifolia,
Fabaceae) amino acid that is sold as a mood-enhancing dietary supplement. The
sale of R. crenulata, which is less expensive
than R. rosea according to the authors of the
paper, could be a case of economically motivated adulteration, but could also
be due to the interchangeable use of some of the Rhodiola
species in TCM. In China, different species (e.g., R. algida,
R. crenulata, R. kirilowii,
R. quadrifida, R.
sachalinensis, R. yunnanensis)
can be used for the same conditions depending on local traditions and
availability.2-4 The chemical composition of some of these species
was found to differ according to Liu et al.,5 but the pharmacological
effects are considered similar. To our knowledge, there are no data that
indicate that the use of R. crenulata is
unsafe; therefore, the presence of R. crenulata in
dietary supplements labeled to contain R. rosea is not
a safety concern. However, most of the available human clinical studies have
been carried out using R. rosea;6
therefore, the scientific data in support of the benefits of R. rosea for mental and physical fatigue are more
compelling.
The paper also demonstrates one of the
shortcomings of using a chemometric approach to detect adulteration of finished
products containing botanical ingredients. While multivariate statistics work
well with crude raw materials, where processing can be standardized,
differences in the manufacturing process, and the addition of various
excipients, may modify the chemical fingerprint of the finished product to an
extent where chemometric models no longer provide useful results. Interestingly
enough, the use of a relatively simple HPTLC analysis was more successful in
the detection of adulteration than the 1H NMR approach. While the
experimental part is well done, the paper would have benefitted if one or
several botanically authenticated materials was included in the work.
References
1.
European Medicines Agency Committee on Herbal Medicinal
Products (HMPC). Community herbal
monograph on Rhodiola rosea L., rhizoma et radix. London:
European Medicines Agency; 2012. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_Community_herbal_monograph/2012/05/WC500127863.pdf. Accessed January 6, 2016.
2.
Qi
Y-J, Cui S, Lu D-X, et al. Effects of the aqueous extract of a Tibetan herb, Rhodiola algida var. tangutica on
proliferation and HIF-1α, HIF-2α expression in MCF-7 cells under hypoxic
condition in vitro. Cancer Cell Int. 2015;15:81.
Doi: 10.1186/s12935-015-0225-x.
3.
Xin T, Li X, Yao H, et al. Survey of commercial Rhodiola
products revealed species diversity and potential safety issues. Sci Rep. 2015;5:8337. doi: 10.1038/srep08337.
4.
Rhodiola. Shen-Nong Limited website. Available at: http://www.shen-nong.com/eng/herbal/hongjingtian.html. Accessed January 6, 2016.
5.
Liu
Z, Liu Y, Liu C, et al. The chemotaxonomic classification of Rhodiola plants and its correlation with morphological
characteristics and genetic taxonomy. Chem Cent J. 2013;7(1):118.
Doi: 10.1186/1752-153X-7-118.
6. Brown RP, Gerbarg PL, Ramazanov Z. Rhodiola rosea: a phytomedicinal overview. HerbalGram. 2002;(56):40-52.